An oral elastic mandibular advancement device for obstructive sleep apnea

Area of Science:

• Sleep Medicine
• Respiratory Physiology
• Medical Devices

Background:

• Obstructive sleep apnea (OSA) is a common sleep disorder characterized by repeated airway collapse.
• Oral mandibular advancement devices (MADs) are a recognized treatment for OSA.
• Elastic mandibular advancement devices (EMAs) represent a newer therapeutic option.

Purpose of the Study:

• To evaluate the efficacy of a novel elastic mandibular advancement device (EMA) in preventing pharyngeal airway closure during sleep in OSA patients.
• To determine if the effectiveness of EMA therapy, assessed by polysomnography, is influenced by the location of airway obstruction.

Main Methods:

• Overnight polysomnography was conducted on 28 untreated OSA patients with and without EMA.
• Airway closure site (oropharynx vs. lower pharynx) was identified using oropharyngeal pressure during NREM sleep.
• A subset of 12 patients underwent a third polysomnogram to confirm airway closure location.

Main Results:

• The mean apnea-hypopnea index (AHI) significantly decreased from 52.6 events/h without EMA to 21.2 events/h with EMA.
• 68% of subjects experienced at least a 50% reduction in AHI when using the EMA.
• Patients with lower pharyngeal airway closure showed substantial AHI reduction (>80%), suggesting EMA efficacy across different obstruction sites.

Conclusions:

• The elastic mandibular advancement device (EMA) is an effective treatment for obstructive sleep apnea (OSA).
• Polysomnographic severity and specific airway closure site should not preclude patients from considering EMA therapy.